Skip to main content

Are you Dr. Jiang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 52 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Hua Jiang, MD is an infectious disease specialist in Claremont, California. He is currently licensed to practice medicine in California, Rhode Island, and Massachusetts. He is affiliated with San Antonio Regional Hospital, San Dimas Community Hospital, and Emanate Health Foothill Presbyterian Hospital.

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1996 - 1999
  • Brown University
    Brown UniversityResidency, Internal Medicine, 1993 - 1996
  • Shanghai Medical University
    Shanghai Medical UniversityClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2025
  • MA State Medical License
    MA State Medical License 1996 - 2007
  • RI State Medical License
    RI State Medical License 1996 - 1997
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China
    Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of ChinaMay 26th, 2021
  • Quantum Frequency Doubling in the Topological Insulator Bi2Se3
    Quantum Frequency Doubling in the Topological Insulator Bi2Se3January 29th, 2021
  • Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers Amid CXC Chemokines in Ovarian Carcinoma Microenvironment
    Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers Amid CXC Chemokines in Ovarian Carcinoma MicroenvironmentJanuary 28th, 2021
  • Join now to see all

Hospital Affiliations